Halozyme Therapeutics shares owned by Schonfeld Strategic Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Schonfeld Strategic Advisors
from 13F filings
Historical chart of Schonfeld Strategic Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Schonfeld Strategic Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $244k | 3.6k | 67.30 |
| 2025-09-30 | $4.5M | 62k | 73.34 |
| 2025-06-30 | $3.2M | 61k | 52.02 |
| 2025-03-31 | $288k | 4.5k | 63.81 |
| 2024-09-30 | $357k | 6.2k | 57.24 |
| 2024-06-30 | $1.4M | 26k | 52.36 |
| 2023-12-31 | $1.3M | 35k | 36.96 |
| 2023-09-30 | $250k | 6.6k | 38.20 |
| 2023-03-31 | $1.1M | 28k | 38.19 |
| 2022-12-31 | $19M | 331k | 56.90 |
| 2022-09-30 | $15M | 389k | 39.54 |
| 2022-06-30 | $13M | 294k | 44.00 |
| 2022-03-31 | $8.0M | 202k | 39.88 |
| 2021-12-31 | $7.5M | 186k | 40.21 |
| 2021-09-30 | $5.7M | 140k | 40.68 |
| 2021-06-30 | $12M | 263k | 45.41 |
| 2021-03-31 | $7.2M | 173k | 41.69 |
| 2020-12-31 | $1.8M | 42k | 42.69 |
| 2020-09-30 | $2.0k | 72k | 0.03 |
| 2020-06-30 | $1.6M | 60k | 26.81 |
| 2020-03-31 | $498k | 28k | 17.98 |
| 2019-06-30 | $983k | 57k | 17.19 |
| 2019-03-31 | $2.8M | 177k | 16.11 |
| 2018-12-31 | $336k | 23k | 14.61 |
| 2016-12-31 | $696k | 70k | 9.88 |
More positions owned by Schonfeld Strategic Advisors
View all positions for Schonfeld Strategic Advisors